Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) EBIT Margin: 2017-2025

Historic EBIT Margin for Assembly Biosciences (ASMB) over the last 6 years, with Sep 2025 value amounting to -100.87%.

  • Assembly Biosciences' EBIT Margin rose 5919.00% to -100.87% in Q3 2025 from the same period last year, while for Sep 2025 it was -116.83%, marking a year-over-year increase of 4712.00%. This contributed to the annual value of -159.26% for FY2024, which is 74324.00% up from last year.
  • Per Assembly Biosciences' latest filing, its EBIT Margin stood at -100.87% for Q3 2025, which was up 12.47% from -115.24% recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' EBIT Margin peaked at -100.87% during Q3 2025, and registered a low of -301.81% during Q3 2021.
  • Its 3-year average for EBIT Margin is -142.77%, with a median of -149.88% in 2024.
  • Per our database at Business Quant, Assembly Biosciences' EBIT Margin tumbled by 29,019bps in 2021 and then soared by 7,992bps in 2025.
  • Quarterly analysis of 4 years shows Assembly Biosciences' EBIT Margin stood at -301.81% in 2021, then reached -175.22% in 2023, then skyrocketed by 1,847bps to -156.75% in 2024, then spiked by 5,919bps to -100.87% in 2025.
  • Its EBIT Margin stands at -100.87% for Q3 2025, versus -115.24% for Q2 2025 and -105.54% for Q1 2025.